The BRAVE Coalition Foundation has received a substantial donation from Johnson & Johnson, reinforcing the company's commitment to supporting breast cancer survivors and advancing patient-centered reconstruction education. This contribution continues support that began in 2018 and reflects a shared dedication to empowering women with knowledge, advocacy, and access throughout their breast reconstruction journey.
Johnson & Johnson's ongoing support advances the foundation's mission of advocacy, education, and equitable access, ensuring women have resources to make informed decisions about their recovery following breast cancer. "Support like this allows us to expand our reach and deepen our impact," said Lisa Shumpert, President of BRAVE Coalition Foundation. "Johnson & Johnson's continued investment underscores the importance of standing beside patients throughout their entire reconstruction and healing process."
Through initiatives including patient education programs, surgeon collaboration, community outreach, and survivor resources, the organization works to remove barriers to care and elevate awareness around breast reconstruction options regardless of insurance coverage or socio-economic status. This contribution will help further these efforts, enabling continued advocacy for informed choice, access, and empowerment for breast cancer survivors nationwide.
The foundation, founded in 2012, is dedicated to promoting education and awareness about resources for breast cancer survivors concerning breast reconstruction options. The organization believes every woman should have the right to decide how they shape their recovery from breast cancer. More information about the BRAVE Coalition Foundation is available at https://www.bravecoalition.org.
